The two major influences on the outcome of Pancreatic Cancer are the individual genetic changes in the cancer and the submissive tumour microenvironment. This application lays the groundwork for a new drug that favourably alters the tumour microenvironment. The drug should be useful for ALL patients regardless of the state of progression of the disease. This will be a major breakthrough in disease treatment.

Professor Jennifer Gamble and Professor Mathew Vadas, AO
Research Reports
Click to download progress reporting on the outcomes of this research.